Psychosocial adaptation and cellular immunity in breast cancer patients in the weeks after surgery: An exploratory study

Journal of Psychosomatic Research

Volumn 67, Issue 5, 2009, Pages 369-376

  Blomberg, Bonnie B ^a,c   Alvarez, Juan P ^a   Diaz, Alain ^a   Romero, Maria G ^a   Lechner, Suzanne C ^b   Carver, Charles S ^b   Holley, Heather ^b   Antoni, Michael H ^b,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b University of Miami   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Anxiety; Breast cancer; Mood; Quality of life; Th1 cytokines

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANXIETY; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; EMOTIONAL STRESS; FEMALE; HEALTH BEHAVIOR; HELPER CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTOPERATIVE PERIOD; PSYCHOSOCIAL CARE;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ANXIETY; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, CELLULAR; INDIVIDUALITY; INTERFERON-GAMMA; INTERLEUKIN-12; LIFE CHANGE EVENTS; LYMPHOCYTE COUNT; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PSYCHONEUROIMMUNOLOGY; QUALITY OF LIFE; SICK ROLE; STATISTICS AS TOPIC; TH1 CELLS;

EID: 70349869334     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2009.05.016     Document Type: Article

References (58)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Stanton A.L., and Snider P.R. Coping with a breast cancer diagnosis: A prospective study. Health Psychol 12 (1993) 16-23
3. Andrykowski M.A., Cordova M.J., Studs J.L., and Miller T.W. Posttraumatic stress disorder after treatment for breast cancer: Prevalence of diagnosis and use of the PTSD Checklist-Civilian Version (PCL-C) as a screening instrument. J Consult Clin Psychol 66 (1998) 586-590
4. Gottschalk L.A., and Hoigaard M.J. The emotional impact of mastectomy. Psychiatry Res 17 (1986) 153-167
5. Jacobsen P.B., Bovbjerg D.H., and Redd W.H. Anticipatory anxiety in women receiving chemotherapy for breast cancer. Health Psychol 12 (1993) 469-475
6. Jacobsen P.B., Bovbjerg D.H., Schwartz MD., Hudis C.A., Gilewsky T.A., and Norton L. Conditioned emotional distress in women receiving chemotherapy for breast cancer. J Consult Clin Psychol 63 (1995) 108-114
7. Kaplan H.S. A neglected issue: The sexual side-effects of current treatments for breast cancer. Can J Hum Sex 3 (1994) 151-163
8. Hann D.M., Jacobsen P.B., Azzarello L.M., Martin S.C., and Greenberg H. Fatigue and quality of life following radiotherapy for breast cancer: A comparative study. J Clin Psychol Med Settings 5 (1998) 19-33
9. Deadman J.M., Dewey M.J., Owens R.G., Leinster S.J., and Slade P.D. Threat and loss in breast cancer. Psychol. Med 19 (1989) 677-681
10. Glanz K., and Lerman C. Psychosocial impact of breast cancer: A critical review. Ann Behav Med 14 (1992) 204-212
11. Schag C.A., Ganz P.A., Polinsky M.L., Fred C., Hirji K., and Peterson L. Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol 11 (1993) 783-793
12. Longman A.J., Braden C.J., and Mishel M.H. Side effects burden in women with breast cancer. Cancer Pract 4 (1996) 274-280
13. Spiegel D. Cancer and depression. Br J Psychiatry Suppl 30 (1996) 109-116
14. Carver C.S., and Scheier M.F. On the self-regulation of behavior (1998), Cambridge University Press, New York
15. Antoni M.H., Lechner S.C., Kazi A., et al. How stress management improves quality of life after treatment for breast cancer. J Consult Clin Psychol 74 (2006) 1143-1152
16. Carver C.S., Smith R.G., Antoni M.H., Petronis V.M., Weiss S., and Derhagopian R.P. Optimistic personality and psychosocial well-being during treatment predict psychosocial well-being among long-term survivors of breast cancer. Health Psychol 24 (2005) 508-516
17. Antoni M.H., and Lutgendorf S. Psychosocial factors and disease progression in cancer. Curr Dir Psychol Sci 16 (2007) 42-46
18. Andersen BL., Farrar WB., Golden-Kreutz D., Kutz L.A., MacCallum R., Courtney M.E., and Glaser R. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst 90 (1998) 30-36
19. Gruber B., Hersh S., Hall N., et al. Immunologic responses of breast cancer patients to behavioral interventions. Biofeedback Self Regul 18 (1993) 1-22
20. Schedlowski M., Jungk C., Shimanski G., Tewes U., and Schmoll H.J. Effect of behavioral intervention on plasma cortisol and lymphocytes in breast cancer patients: An exploratory study. Psychooncology 3 (1994) 181-187
21. Van der Pompe G., Duivenvoorden H., Antoni M.H., Visser A., and Heijnen C. Effectiveness of short-term group psychotherapy program on endocrine and immune function in breast cancer patients: an exploratory study. J Psychosom Res 42 (1997) 453-466
22. Antoni M.H., Lutgendorf SK., Cole S.W., et al. The influence of bio-behavioral factors on tumor biology: Pathways and mechanisms. Nat Rev Cancer 6 (2006) 240-248
23. Elenkov I.J., and Chrousos G.P. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 966 (2002) 290-303
24. Dhabhar F.S., and McEwen B.S. Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: A potential role for leukocyte trafficking. Brain Behav Immun 11 (1997) 286-306
25. Dhabhar F.S., and McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci U S A 96 (1999) 1059-1064
26. Dhabhar F.S. Stress-induced augmentation of immune function-The role of stress hormones, leukocyte trafficking, and cytokines. Brain Behav Immun 16 (2002) 785-798
27. Webster J.I., Tonelli L., and Sternberg E.M. Neuroendocrine regulation of immunity. Annu Rev Immunol 20 (2002) 125-163
28. Elenkov I.J. Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci 1024 (2004) 138-146
29. Smyth M.J., Hayakawa Y., Takeda K., and Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2 (2002) 850-861
30. Callewaert D.M., Moudgil V.K., Radcliff G., and Waite R. Hormone specific regulation of natural killer cells by cortisol. Direct inactivation of the cytotoxic function of cloned human NK cells without an effect on cellular proliferation. FEBS Lett 285 (1991) 108-110
31. Zhou J., Olsen S., Moldovan J., Fu X., Sarkar F.H., Moudgil V.K., and Callewaert D.M. Glucocorticoid regulation of natural cytotoxicity: Effects of cortisol on the phenotype and function of a cloned human natural killer cell line. Cell Immunol 178 (1997) 108-116
32. 2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J Immunol 161 (1998) 2723-2730
33. Vitale C., Chiossone L., Cantoni C., et al. The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity. Eur J Immunol 34 (2004) 3028-3038
34. Mavoungou E., Bouyou-Akotet M.K., and Kremsner P.G. Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30). Clin Exp Immunol 139 (2005) 287-296
35. Ortaldo J.R., Mason A., and Overton R. Lymphokine-activated killer cells. Analysis of progenitors and effectors. J Exp Med 164 (1986) 1193-1205
36. Ferrini S., Zarcone D., Viale M., Cerruti G., Millo R., Moretta A., and Grossi C.E. Morphologic and functional characterization of human peripheral blood T cells expressing the T cell receptor γ/δ. Eur J Immunol 19 (1989) 1183-1188
37. Lee R.K., Spielman J., Zhao D.Y., Olsen K.J., and Podack E.R. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J Immunol 157 (1996) 1919-1925
38. McVicar D.W., Merchant R.E., Merchant L.H., and Young H.F. Corticosteroids inhibit the generation of lymphokine-activated killer activity in vitro. Cancer Immunol Immunother 29 (1989) 211-218
39. Ruschen S., Stellberg W., and Warnatz H. Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls. Clin Exp Immunol 89 (1992) 32-37
40. Imai Y., Sugita M., Nakamura S., Toriyama S., and Ohno S. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease. Curr Eye Res 22 (2001) 312-318
41. Kruse N., Moriabadi N.F., Toyka K.V., and Rieckmann P. Characterization of early immunological responses in primary cultures of differentially activated human peripheral mononuclear cells. J Immunol Methods 247 (2001) 131-139
42. Derogatis L.R. Affects Balance Scale (1996), Clinical Psychometric Research, Baltimore (Md)
43. Cella D.F., Tulsky D.S., Gray G., et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11 (1993) 570-579
44. Reichert T., DeBruyère M., Deneys V., et al. Lymphocyte subset reference ranges in adult Caucasians. Clin Immunol Immunopathol 60 (1991) 190-208
45. Nicolini A., Ferrari P., Spinelli R., et al. Cell-mediated immunity in breast cancer patients. Biomed Pharmacother 50 (1996) 337-343
46. Spencer S., Lehman J., Wynings C., et al. Concerns about breast cancer and relations to psychological well-being in a multi-ethnic sample of early stage patients. Health Psychol 18 (1999) 159-169
47. Carver C.S., Lehman J.M., and Antoni M.H. Dispositional pessimism predicts illness-related disruption of social and recreational activities among breast cancer patients. J Pers Soc Psychol 84 (2003) 813-821
48. Ben-Eliyahu S., Page G., Yimura R., et al. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 80 (1999) 880-888
49. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: Immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 17 Suppl 1 (2003) S27-S36
50. Shakhar G., and Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: Could they reduce recurrence rates in oncological patients?. Ann Surg Oncol 16 (2003) 972-992
51. Andersen B.L., Farrar W.B., Golden-Kreutz D.M., et al. Psychological, behavioral, and immune changes after a psychological intervention: A clinical trial. J Clin Oncol 22 (2004) 3570-3580
52. McGregor B.A., Antoni M.H., Boyers A., Alferi S.M., Blomberg B.B., and Carver C.S. Cognitive-behavioral stress management increases benefit finding and immune function among women with early-stage breast cancer. J Psychosom Res 56 (2004) 1-8
53. Lutgendorf S.K., Cole S., Costanzo E., et al. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res 9 (2003) 4514-4521
54. Gan X., Zhang L., Solomon G., et al. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic function: Inhibition of cytokine secretion, target binding, and programming for cytotoxicity. Brain Behav Immun 16 (2002) 227-246
55. Lutgendorf S.K., Lamkin D.M., DeGeest K., et al. Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients. Brain Behav Immun 22 (2008) 890-900
56. Witek-Janusek L., Gabram S., and Mathews H.L. Psychologic stress, reduced NK cell activity, and cytokine dysregulation in women experiencing diagnostic breast biopsy. Psychoneuroendocrinology 32 (2007) 22-35
57. Costanzo E.S., Lutgendorf S.K., Sood A.K., et al. Psychosocial factors and interleukin-6 among women with advanced ovarian cancer. Cancer 104 (2005) 305-313
58. Antoni M.H., Wimberly S.R., Lechner S.C., et al. Reduction of cancer-specific thought intrusions and anxiety symptoms with a stress management intervention among women undergoing treatment for breast cancer. Am J Psychiatry 163 (2006) 1791-1797